CLINICAL_TRIALS
trial_result
· 2011-01-24
Clinical Trial Update: Budesonide / Formoterol in Treatment of Exacerbations of COPD [Phase 2]
Summary
A Phase 2 trial evaluating budesonide/formoterol for treatment of COPD exacerbations has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED